Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma.
Where this comes from
- Record sourced from PubMed, PMID 34506831.
- Also identified by DOI 10.1016/j.radonc.2021.08.021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We analyzed CTCAE adverse events of sequential Carbon Ion radiotherapy (CIRT) and immune checkpoint inhibitors (ICIs) in advanced melanoma patients. The frequencies of early and late adverse events (AEs) were 100% and 82% of patients, respectively. The frequency of G3+ AEs was in line with the literature.
Medical subject headings
- Heavy Ion Radiotherapy
- Melanoma